17.79 USD
↗ 0.23 (1.31%)AT CLOSE (11:59 AM EDT)
Sensei Biotherapeutics, Inc. Common Stock
SNSENASDAQ • USD
17.77
↘ 0.03 (0.14%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
17.77
↘ 0.03 (0.14%)
Market: CLOSED
Open?$18.47
High?$19.16
Low?$17.29
Prev. Close?$17.56
Volume?21.1K
Avg. Volume?31.9K
VWAP?$18.32
Rel. Volume?0.66x
Bid / Ask
Bid?$11.18 × 100
Ask?$21.35 × 100
Spread?$10.17
Midpoint?$16.27
Valuation & Ratios
Market Cap?23.9M
Shares Out?1.3M
Float?775.9K
Float %?57.9%
P/E Ratio?N/A
P/B Ratio?-0.17
EPS?-$137.46
Dividend?0.00%
Ex-Dividend?N/A
Shares of Sensei Biotherapeutics, Inc. Common Stock (SNSE) are trading at $17.79. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (134.4%) and a bullish Golden Cross on the moving averages. On the valuation side, SNSE appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of May 22, 2026.
News
Profile
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.
Employees
29
Market Cap
23.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-02-04
Address
1405 RESEARCH BLVD, SUITE 125
ROCKVILLE, MD 20850
Phone: (240) 243-8000
ROCKVILLE, MD 20850
Phone: (240) 243-8000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.95Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?107.54%Squeeze Risk
Short Interest?834.4K
Days to Cover?27.1
Free Float775.9K
Avg Daily Volume30.8K
Settlement Date2026-04-30
Financial Health
Current Ratio?14.39Strong
Quick Ratio?14.39Strong
Cash Ratio?10.73Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.17CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.7CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?134.4%STRONG▾
Peers50
S&P97
ROA?-89.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-24114000
Enterprise Value?$-128433870
Fundamentals ratios updated end of day